These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3781677)

  • 21. Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974-1993.
    Hunziker T; Bruppacher R; Kuenzi UP; Maibach R; Braunschweig S; Halter F; Hoigné RV
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):159-63. PubMed ID: 11998541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [3/10 Undesirable side-effects of drugs: causes, consequences, prevention].
    Soins; 2006 Apr; (704):69-70. PubMed ID: 16704014
    [No Abstract]   [Full Text] [Related]  

  • 23. Improving the quality of adverse drug reaction reporting by 4th-year medical students.
    Rosebraugh CJ; Tsong Y; Zhou F; Chen M; Mackey AC; Flowers C; Toyer D; Flockhart DA; Honig PK
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):97-101. PubMed ID: 12642973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studying the causes of adverse drug reactions: circumvent the warning-interfered bias using the case-case comparison approach.
    Wang LY; Lee WC
    J Clin Epidemiol; 2008 May; 61(5):516. PubMed ID: 18394547
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of an adverse drug reaction monitoring program in nursing homes.
    Soon JA
    Can J Hosp Pharm; 1985 Aug; 38(4):120-5. PubMed ID: 10274971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection and evaluation of adverse drug effects].
    Thürmann PA; Schmitt K
    Med Klin (Munich); 2000 May; 95(1 Spec No):4-8. PubMed ID: 10851841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M; Eliasson E; Ohlén G; Bergman U
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The epidemiology of adverse drug reactions. A review and perspective.
    Gardner P; Cluff LE
    Johns Hopkins Med J; 1970 Feb; 126(2):77-87. PubMed ID: 4909109
    [No Abstract]   [Full Text] [Related]  

  • 29. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
    Fick DM; Cooper JW; Wade WE; Waller JL; Maclean JR; Beers MH
    Arch Intern Med; 2003 Dec 8-22; 163(22):2716-24. PubMed ID: 14662625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Under-reporting of serious adverse drug reactions in Sweden.
    Bäckström M; Mjörndal T; Dahlqvist R
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonimmunologic adverse drug reactions. How to recognize and categorize some common reactions.
    Bernstein JA
    Postgrad Med; 1995 Jul; 98(1):120-2, 125-6. PubMed ID: 7603941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure.
    Feldmann U
    Biometrics; 1993 Jun; 49(2):419-28. PubMed ID: 8369378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
    Aronson JK
    J Eval Clin Pract; 2005 Apr; 11(2):195-208. PubMed ID: 15813716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Operational assessment of adverse drug reaction: a comparison of four algorithms (author's transl)].
    Begaud B; Boisseau A; Albin H; Dangoumau J
    Therapie; 1981; 36(1):65-70. PubMed ID: 7233374
    [No Abstract]   [Full Text] [Related]  

  • 36. Physician attitudes toward pharmacists counseling patients on adverse drug reactions.
    Moss RL; Garnett WR; Steiner KC
    Am J Hosp Pharm; 1980 Feb; 37(2):243-7. PubMed ID: 7361800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients.
    McKenzie MW; Stewart RB; Weiss CF; Cluff LE
    Am J Hosp Pharm; 1973 Oct; 30(10):898-903. PubMed ID: 4747029
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study.
    Hutchison LC; Jones SK; West DS; Wei JY
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):144-53. PubMed ID: 16860261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adverse drug reactions in the elderly].
    Doucet J; Queneau P
    Bull Acad Natl Med; 2005 Nov; 189(8):1693-707; discussion 1708-9. PubMed ID: 16737095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.